Business Weekly - Cambridge, UK

Thursday 29 May 2008, 10:00 am to 4:30 pm

Novotel Hotel, London, St Pancras

Program

Licensing has emerged as a cornerstone for the commercialisation of life science technology, from university to spin-out, from SME to big pharma, and for pharmaceutical companies seeking to enhance their development portfolio. Understanding the basis of valuing a license is an essential prerequisite to reaching a commercial licensing agreement.

This MasterClass provides an opportunity to refresh your understanding of license valuation, and to learn new approaches to dealing with future uncertainty. The MasterClass will provide a non-mathematical overview of valuation concepts applicable to biotechnology and pharmaceutical licenses -it is based on the use of Excel models and introduces @Risk simulation software.

Fundamentals: Capital Asset Pricing Model, Net Present Value, Discounted Cash Flow

Valuation under Uncertainty: Expected NPV, Using @Risk

Forecasting Sales: Two Methods for Projecting Future Sales

Value Share: How eNPV is divided between licensor and licensee

Case Study: Delegates will work in teams to derive a license valuation in a simulated case

Who Should Participate?

CEOs, FDs and BDDs of life science companies, Patent Attorneys, solicitors and other professional advisors, Licensing executives, Venture capital executives, investors and business analysts, Technology transfer executives

Advanced registration is required - attendance is limited.

The registration Fee of £450+VAT includes the MasterClass workbook, lunch and refreshments. Second delegate from the same organisation receives a 25% discount; full time students may register for £150+VAT.

Payment by cash, cheque or BACS is required in advance of the MasterClass; sorry we don't accept credit cards.

Click to open the Registration Form - save the Form as a MS Word file, complete and return by email (info@captum.com )  or fax (0115 988 6005)